Publications by authors named "Kristian Funck"

Claim this Profile
S
Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?
Kristian Løkke Funck, Britt Borregaard, Kenneth Egstrup, Eskild Klausen Fredslund, Tine Willum Hansen

BMJ Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of colchicine on platelet aggregation in patients with type 2 diabetes: Results from a randomized placebo-controlled trial.
Jonathan M Baier, Kristian L Funck, Liv Vernstrøm, Søren Gullaksen, Per L Poulsen

J Diabetes Complications· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial.
Søren Gullaksen, Liv Vernstrøm, Steffen Skovgaard Sørensen, Kristian Løkke Funck, Line Petersen

J Diabetes Complications· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [F]FDG PET/CT in patients with type 2 diabetes.
Jonathan M Baier, Kristian L Funck, Anna Dons-Jensen, Ole L Munk, Lars P Tolbod

EJNMMI Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: A randomized placebo-controlled trial.
Jonathan M Baier, Kristian L Funck, Liv Vernstrøm, Søren Gullaksen, Esben Laugesen

Eur J Prev Cardiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of cardiovascular markers and diseases using retinal fundus images and deep learning: a systematic scoping review.
Livie Yumeng Li, Anders Aasted Isaksen, Benjamin Lebiecka-Johansen, Kristian Funck, Vajira Thambawita

Eur Heart J Digit Health· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian L Funck

Diabetologia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian L Funck

Diabetologia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.
Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen, Kristian L Funck, Esben Laugesen

Diabetes Obes Metab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Arteriograph 24 for evaluation of 24-hour pulse wave velocity and central blood pressure in patients with type 2 diabetes and non-diabetic controls.
Esben Laugesen, Amalie Nørkjær Svendsen, Liv Vernstrøm, Lene Halkjær, Anna Dons-Jensen, Kristian L Funck

Blood Press Monit· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian L Funck

J Diabetes Complications· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian L Funck

Diabetologia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease.
Jeyanthini Risikesan, Sara Heebøll, Indumathi Kumarathas, Kristian L Funck, Esben Søndergaard

Atherosclerosis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
Søren Gullaksen, Liv Vernstrøm, Steffen Skovgaard Sørensen, Kristian Løkke Funck, Line Petersen

J Diabetes Complications· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls.
Steffen S Sørensen, Søren Gullaksen, Liv Vernstrøm, Steffen Ringgaard, Christoffer Laustsen, Kristian L Funck

Nephrol Dial Transplant· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study.
Kristian Løkke Funck, Lasse Bjerg, Anders Aasted Isaksen, Annelli Sandbæk, Erik Lerkevang Grove

Cardiovasc Diabetol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low physical activity is associated with impaired endothelial function in patients with type 2 diabetes and controls after 5 years of follow-up.
Jonathan Mathias Baier, Kristian Løkke Funck, Liv Vernstrøm, Esben Laugesen, Per Løgstrup Poulsen

BMC Endocr Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study.
Kristian L Funck, Esben Laugesen, Pernille Høyem, Brian Stausbøl-Grøn, Won Y Kim

Diabetol Metab Syndr· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019.
Kristian L Funck, Jakob S Knudsen, Troels K Hansen, Reimar W Thomsen, Erik L Grove

Diabetes Obes Metab· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary plaque burden in Turner syndrome a coronary computed tomography angiography study.
Kristian L Funck, Ricardo P J Budde, Mette H Viuff, Jan Wen, Jesper M Jensen

Heart Vessels· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal vessel reactivity is not attenuated in patients with type 2 diabetes compared with matched controls and is associated with peripheral endothelial function in controls.
Jonathan Mathias Baier, Kristian Løkke Funck, Line Petersen, Liv Vernstrøm, Søren T Knudsen

J Diabetes Complications· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.
Søren Gullaksen, Kristian Løkke Funck, Esben Laugesen, Troels Krarup Hansen, Damini Dey

Diab Vasc Dis Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of biomarkers using a novel proximity extension assay in patients with ST-elevation myocardial infarction.
Archana Kulasingam, Anne-Mette Hvas, Erik Lerkevang Grove, Kristian Løkke Funck, Steen Dalby Kristensen

Thromb Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplatelet effect of aspirin during 24h in patients with type 2 diabetes without cardiovascular disease.
Liv Vernstrøm, Kristian Løkke Funck, Erik Lerkevang Grove, Esben Laugesen, Jonathan Mathias Baier

Thromb Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes.
Monija Mrgan, Kristian L Funck, Sara Gaur, Kristian A Øvrehus, Damini Dey

Diab Vasc Dis Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis